Histomorphological changes in murine fibrosarcoma after hypericin-based photodynamic therapy

Phytomedicine

Volumn 14, Issue 2-3, 2007, Pages 172-178

  Bobrov, Nikita ^a   Čavarga, Ivan ^b   Longauer, František ^a   Rybárová, Silvia ^a   Fedoročko, Peter ^a   Brezáni, Peter ^a   Miškovský, Pavol ^a,c   Mirossay, Ladislav ^a   Štubňa, Ján ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^c INTERNATIONAL LASER CENTER   (Slovakia)

Author keywords

Cancerotherapy; Hypericin; Photodynamic therapy; Tumour

Indexed keywords

HYPERICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; EDEMA; FIBROSARCOMA; HISTOLOGY; INFLAMMATION; INOCULATION; LASER; LIVER CONGESTION; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SINGLE DRUG DOSE; THROMBOSIS; TISSUE NECROSIS; TUMOR VOLUME; VASODILATATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FIBROSARCOMA; HUMANS; HYPERICUM; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C3H; PERYLENE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PHYTOTHERAPY; PLANT EXTRACTS; RADIATION DOSAGE;

ANIMALIA; MURINAE; MUS;

EID: 33846348020     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2006.09.017     Document Type: Article

References (19)

1. Blank M., Kostenich G., Lavie G., Kimel S., Keisari Y., and Orenstein A. Wavelength-dependent properties of photodynamic therapy using hypericin in vitro and in an animal model. Photochem. Photobiol. 76 (2002) 335-340
2. Čavarga I., Brezáni P., Čekanová-Figurová M., Solár P., Fedoročko P., and Miškovský P. Photodynamic therapy of murine fibrosarcoma with topical and systemic administration of hypericin. Phytomedicine 8 (2001) 325-330
3. Čavarga I., Brezáni P., Fedoročko P., Miškovský P., Bobrov N., Longauer F., Rybárová S., Mirossay L., and Štubňa J. Photoinduced antitumour effect of hypericin can be enhanced by fractionated dosing. Phytomedicine 12 (2005) 680-683
4. Chen B., Xu Y., Roskams T., Delaey E., Agostinis P., Vandenheede J.R., and DeWitte P. Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effect in the RIF-l mouse tumor model. Int. J. Cancer 93 (2001) 275-282
5. Chen B., Zupko I., and DeWitte P. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy. Int. J. Oncol. 18 (2001) 737-742
6. Chen B., Roskams T., and DeWitte P. Antivascular tumor eradication by hypericin mediated photodynamic therapy. Photochem. Photobiol. 76 (2002) 509-513
7. Chen B., Roskams T., and DeWitte P. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hypertermia. Lasers Surg. Med. 31 (2002) 158-163
8. Chen B., Pogue B.W., Hoopes P.J., and Hasan Y. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Int. J. Radiat. Oncol. Biol. Phys. 61 (2005) 1216-1226
9. Chung P.S., Rhee C.K., Kim K.H., Paek W., Chung J., Paiva M.B., Eshraghi A.A., Castro D.J., and Saxton R.E. Intratumoral hypericin and KPT laser therapy for transplanted squamous cell carcinoma. Laryngoscope 110 (2000) 1312-1316
10. Dolmans D.E.J.G.J., Kadambi A., Hill J.S., Waters C.A., Robinson B.C., Walker J.P., Fukumura D., and Jain R.K. Vascular accumulation of novel photosensitizer MV6401 cases selective thrombosis in tumor vessels following photodynamic therapy. Cancer Res. 62 (2002) 2151-2156
11. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., and Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90 (1998) 889-905
12. Engelbrecht B.W., Menon C.H., Kachur A.V., Hahn S.M., and Fraker D.L. Photofrin mediated photodynamic therapy induces vascular occlusion and apoptosis in human sarcoma xenograft model. Cancer Res. 59 (1999) 4334-4342
13. Hofer M., Hoferová Z., Pospíšil M., Znojil V., and Chramostová K. Effects of adenosine on the growth of murine G:5:113 fibrosarcoma cells in vitro. Folia Biol. 49 (2003) 207-210
14. Höpfner M., Maaser K., Theiss A., Lenz M., Sutter A.P., Kashtan H., von Lampe B., Riecken E.O., Zeitz M., and Scherübl H. Hypericin activated by incoherent light source has photodynamic effects on esophageal cancer cells. Int. J. Colorectal Dis. 18 (2003) 239-247
15. Nakaseko H., Kobayashi M., Akita Y., Tamada Y., and Matsumoto Y. Histological changes and involvement of apoptosis after photodynamic therapy for actinic keratoses. Br. J. Dermatol. 148 (2003) 122-127
16. Peng Q., Warloe T., Moan J., Godal A., Apricena F., Giercksky K.E., and Nesland J.M. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose photofrin in human tumor xenografts. Cancer Res. 61 (2001) 5824-5832
17. Solár P., Čavarga I., Horfmanová J., Čekanová-Figurová M., Miškovský P., Brezáni P., Hrčková G., Kozubík A., and Fedoročko P. Effect of acetazolamide on hypericin photocytotoxicity. Planta Med. 68 (2002) 658-660
18. Tsoukas M.M., González S., Flotte T.J., Anderson R.R., Sherwood M.E., and Kollias N. Wavelength and fluence effect on vascular damage with photodynamic therapy on skin. J. Invest. Dermatol. 114 (2000) 303-308
19. Zupko I., Kamuhabwa A.R., D'Hallewin M.A., Baert L., and DeWitte P. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors. Int. J. Oncol. 18 (2001) 1099-1105